ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CORT Corcept Therapeutics Inc

28.15
-0.44 (-1.54%)
Jun 19 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Corcept Therapeutics Inc CORT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.44 -1.54% 28.15 00:00:03
Open Price Low Price High Price Close Price Prev Close
28.62 28.09 28.93 28.15 28.59
more quote information »

Recent News

Date Time Source Heading
6/06/202418:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/05/202421:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/05/202421:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/05/202421:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/05/202421:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/05/202421:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/05/202421:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/03/202414:15EDGAR2Form 144 - Report of proposed sale of securities
6/03/202414:05EDGAR2Form 144 - Report of proposed sale of securities
6/03/202413:05EDGAR2Form 144 - Report of proposed sale of securities
6/03/202408:00GLOBECorcept Therapeutics Announces Presentations of Results of..
5/31/202416:47EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202416:46EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202416:45EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202416:44EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202416:43EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202416:41EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202416:40EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202416:39EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202416:38EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202416:38EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202416:38EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/31/202416:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
5/30/202421:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/30/202420:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/28/202419:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/28/202413:22EDGAR2Form 144 - Report of proposed sale of securities
5/28/202413:14EDGAR2Form 144 - Report of proposed sale of securities
5/28/202408:00GLOBECorcept Announces Primary Endpoint Met in Pivotal Phase 3..
5/23/202416:11EDGAR2Form 8-K - Current report
5/21/202418:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202418:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202418:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202418:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202418:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202418:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202418:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202418:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/15/202420:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/13/202421:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/13/202412:24EDGAR2Form 144 - Report of proposed sale of securities
5/09/202412:35EDGAR2Form 144 - Report of proposed sale of securities
5/06/202420:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/01/202416:05GLOBECorcept Therapeutics Announces First Quarter Financial..
4/29/202408:00GLOBECorcept Completes Enrollment in Phase 4 CATALYST Trial
4/24/202416:05GLOBECorcept Therapeutics to Announce First Quarter Financial..
4/22/202408:00GLOBECorcept Announces Positive Results From Open-Label Portion..
4/15/202408:00GLOBECorcept Completes Enrollment in Phase 2 DAZALS Trial in..
4/08/202408:00GLOBECorcept Completes Enrollment in Pivotal Phase 3 Rosella..
4/01/202408:00GLOBECorcept Completes Enrollment in Phase 3 Gradient Trial of..

Your Recent History

Delayed Upgrade Clock